Anti‐B cell and anti‐cytokine therapy for the treatment of post‐transplant lymphoproliferative disorder: past, present, and future
- 1 June 2001
- journal article
- review article
- Published by Wiley in Transplant Infectious Disease
- Vol. 3 (2) , 104-107
- https://doi.org/10.1034/j.1399-3062.2001.003002104.x
Abstract
Epstein–Barr virus (EBV)‐induced post‐transplant lymphoproliferative disorder (PTLD) is a rare but severe complication of solid organ and bone‐marrow transplantation. When possible, reducti...Keywords
This publication has 14 references indexed in Scilit:
- CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantationBlood, 2000
- Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disordersThe Lancet, 1998
- Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.Journal of Clinical Oncology, 1995
- Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferationThe Lancet, 1995
- Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies.Journal of Clinical Investigation, 1992
- Anti–B-Cell Monoclonal Antibodies in the Treatment of Severe B-Cell Lymphoproliferative Syndrome Following Bone Marrow and Organ TransplantationNew England Journal of Medicine, 1991
- Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases of after solid organ transplantationThe American Journal of Medicine, 1989
- Treatment of B-Cell Lymphoproliferative Disorders with Interferon Alfa and Intravenous Gamma GlobulinNew England Journal of Medicine, 1988
- THE FREQUENCY OF EPSTEIN-BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDRENTransplantation, 1988
- Epstein–Barr Virus-Induced B-Cell Lymphoma after Renal TransplantationNew England Journal of Medicine, 1982